Angiogenesis and p53 at the invading tumor edge: Prognostic markers for colorectal cancer beyond stage

被引:13
作者
Georgiou, L
Minopoulos, G
Lirantzopoulos, N
Fiska-Demetriou, A
Maltezos, E
Sivridis, E
机构
[1] Democritus Univ Thrace, Sch Med, Dept Pathol, Alexandroupolis, Greece
[2] Democritus Univ Thrace, Sch Med, Dept Surg 1, Alexandroupolis, Greece
[3] Democritus Univ Thrace, Sch Med, Dept Anat, Alexandroupolis, Greece
[4] Democritus Univ Thrace, Sch Med, Dept Internal Med 1, Alexandroupolis, Greece
关键词
angiogenesis; p53; bcl-2; prognosis; colorectal cancer;
D O I
10.1016/j.jss.2005.10.002
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Angiogenesis has emerged as a major prognostic factor in many human malignancies and it is a prospective target for cancer therapy. Materials and methods. In this study, we investigated immunohistochemically the angiogenic activity and the expression of p53 and bcl-2 proteins in a series of 170 operable colorectal carcinomas, stage B and C. Results. A high vascular density at the invading tumor front was directly related to nuclear p53 accumulation, and inversely to cytoplasmic expression of bcl-2. Furthermore, high angiogenic activity was significantly associated with lymph node metastasis. Survival analysis showed that Dukes stage and vascular density were the most important and independent prognostic factors in colorectal cancer. Discussion. It is believed that angiogenesis at the invading tumor edge can be used as an independent prognostic marker to identify subgroups of colorectal cancer patients with an unfavorable post-operative outcome. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:118 / 123
页数:6
相关论文
共 36 条
[1]  
Bouvet M, 1998, CANCER RES, V58, P2288
[2]  
CASS AW, 1976, CANCER, V37, P2861, DOI 10.1002/1097-0142(197606)37:6<2861::AID-CNCR2820370643>3.0.CO
[3]  
2-3
[4]   CONTROL OF ANGIOGENESIS IN FIBROBLASTS BY P53 REGULATION OF THROMBOSPONDIN-1 [J].
DAMERON, KM ;
VOLPERT, OV ;
TAINSKY, MA ;
BOUCK, N .
SCIENCE, 1994, 265 (5178) :1582-1584
[5]  
Dukes C, 1937, Proc R Soc Med, V30, P371
[6]  
EISENBERG B, 1982, CANCER, V49, P1131, DOI 10.1002/1097-0142(19820315)49:6<1131::AID-CNCR2820490611>3.0.CO
[7]  
2-T
[8]   Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging [J].
Engel, CJ ;
Bennett, ST ;
Chambers, AF ;
Doig, GS ;
Kerkvliet, N ;
OMalley, FP .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (10) :1260-1265
[9]   Adjuvant therapy for stage II colon cancer: A systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group [J].
Figueredo, A ;
Charette, ML ;
Maroun, J ;
Brouwers, MC ;
Zuraw, L .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3395-3407
[10]  
Giatromanolaki A, 1999, CANCER-AM CANCER SOC, V86, P1421, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1421::AID-CNCR6>3.0.CO